NAT Welcomes Breakthrough in Microbicide Development
Announcement of the CAPRISA trial results marks a major breakthrough HIV prevention
Results of the CAPRISA 004 trial announced yesterday at the International AIDS Conference, showed a vaginal microbicidal gel containing the antiretroviral drug tenofovir (Viread) reduced the risk of HIV infection among women who received it by 39 per cent during a two-and-a-half-year study in South Africa.
New Guidance for Police Investigating Criminal Transmission of HIV
Police and HIV sector work together to produce guidance
New guidance has been produced to help police when investigating allegations of criminal transmission of HIV. The guidance provides police officers with basic facts about HIV and sets out advice on how to deal with complaints about reckless (or intentional) transmission of HIV in a fair and sensitive manner.